From the Gastrointestinal Clinic, Groote Schuur Hospital and Department of Medicine, University of Cape Town, South Africa SUMMARY The oral (PABA) pancreatic function test (PFT), the secretin-pancreozymin test and endoscopic retrograde pancreatography (ERCP) have been carried out in 32 patients with suspected chronic alcohol induced pancreatitis (CAIP) in order to evaluate which, if any, test was most likely to confirm the provisional diagnosis.
Thirty one patients had changes of minimal (n=6) moderate (n=7) or advanced (n=18) chronic pancreatitis on pancreatography, whilst one patient had a pancreas divisum. Eight hour urinary PABA excretion was significantly reduced in patients with moderate and advanced structural changes (p<O0OO1) and correlated significantly with all parameters of the PFT, although eight patients with an abnormal pancreatogram and pancreatic function test had a normal PABA value. The PFT was abnormal in 23 patients, but normal in five patients with an abnormal pancreatogram and low PABA value. Most patients with minimal change pancreatitis had a normal PABA test and PFT. We conclude that pancreatography appears to be the most sensitive method for detecting chronic pancreatic damage and for confirming a clinical diagnosis of chronic alcohol induced pancreatitis. Both 
Methods

PATIEENTS
Thirty two consecutive patients with a clinical diagnosis of chronic alcohol induced pancreatitis based on a history of typical pancreatic pain and chronic excess alcohol ingestion (>80g alcohol per day) were studied as part of their routine pancreatic assessment.
A smaller number of patients were also diabetic (n=8), had biochemical steatorrhoea (n=7) or had a history of previous documented attacks of acute pancreatitis (n= 13). There were 30 men and two women, mean age 45 years (27-58 years) . No patient with an episode of acute pancreatitis within the previous six weeks or a pancreatic cyst was included. Renal and hepatic function were biochemically normal in all subjects and no patient had clinically overt small bowel disease.
For the PABA test the control group (HC) consisted of 18 healthy subjects from the hospital staff, mean age 41 years .
PABA TEST
After an overnight fast subjects took 0-5 g of the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Fluorochem Ltd, Glossop, Derbyshire) dissolved in a Lundh test meal, which acted as a standard stimulus of pancreatic secretion. Water was allowed but food was witheld until four hours after ingestion of the test meal. Urine was collected for eight hours and assayed for aromatic amines as previously described. 6 16 No patient was taking any medication other than paracetamol for analgesia or pancreatic enzyme supplements. These were stopped for 48 hours before the test. All subjects were requested to avoid foods with a high aryl acid content for 24 hours before the test. To ensure that no interference with the laboratory analysis had occurred, a pretest urine sample was also collected and assayed for PABA content. An eight hour urinary excretion of PABA of less than 59% (control mean minus 2 SD) was regarded as abnormal.
SECRETIN-PANCREOZYMIN TEST
Pancreatic exocrine function (standard pancreatic function test) was tested by analysing duodenal contents for volume, mean and maximal bicarbonate output, amylase, trypsin, chymotrypsin and lipase concentration following an intravenous injection of secretin and pancreozymin as previously described. 17 Briefly, after an overnight fast two Salem Sump tubes (Argyle) were passed nasogastrically. Under fluoroscopic control, one tube was positioned in the distal second part of the duodenum and the other in the dependent part of the stomach for continual aspiration of gastric contents. After a 10 minute basal collection which was discarded, an intravenous bolus of Boots secretin 2 U/kg (batch no 91510/4) was given, and the duodenal contents aspirated for six consecutive 10 minute periods. After one hour an intravenous bolus of Boots pancreozymin 1.5 U/kg (batch no 91331/2) was given and a further two 10 minute collections were made.
The volumes of each sample were noted and the bicarbonate, trypsin, chymotrypsin, amylase and lipase concentrations and output analysed on the same day as the test. Trypsin was determined by the method described by Nardi'8 using benzoyl-Iarginine amide hydrochloride as the substrate, and was expressed as units of tryptic activity. Chymotrypsin was measured according to the method of Schwert and Takenaka'9 using N-acetyl-L-tyrosine ethyl ester as substrate.
Amylase was determined using Pimstones modification of the Gomori method20 and the result expressed as milligrams of starch digested by one millilitre of pancreatic juice in 30 minutes at 37°C.
Lipase was measured by Pimstone's modification of the Gomori method21 using alpha-naphthyl laurate as substrate and a diazonium salt as the colour reagent. The result was expressed as the number of micromoles of alpha naphthol liberated by one ml of pancreatic juice in three hours at 37°C. The results for volume, mean and maximal bicarbonate output, amylase and lipase were scored from 0 to 2 and the total used as an arbitrary value for function on a scale from 10 to 0, where 10/10 represented normal function and increasingly abnormal function ranged from 9/10 to 0/10. The percentage of PABA excreted in the urine after eight hours (mean±SEM) was 71-6±1-5 for healthy controls, 52-6±3-2 in the NCP group and 39-2±4 in the chronic calcific pancreatitis group (Fig. 1) . The results according to the pancreatogram gradings were 60-8±2 for minimal 50 8±6 for moderate and 42*9±3-8 for advanced changes (Fig. 2) .
The differences between healthy controls, noncalcific chronic pancreatitis and chronic calcific pancreatitis were significant and for patients with chronic calcific pancreatitis there was no overlap with the healthy control group (HC vs CCP p<0-001; HC vs NCP p<0001; CCP vs NCP p<0-005 (Table 2) and vice versa (Table 3) .
Discussion
Since the introduction of the oral (PABA) pancreatic function test, it has been shown to correlate well with both the secretin-pancreozymin test9 10 Nevertheless, in all these studies there are a number of patients with chronic pancreatitis who have an unequivocally abnormal pancreatogram and yet apparently normal pancreatic exocrine function. The converse is equally true, although in this series no patient had abnormal exocrine function and a Histological proof must remain the final arbiter of whichever test is used to evalute a clinical diagnosis of chronic alcohol induced pancreatitis. Nevertheless, in the majority of patients surgical intervention is unnecessary and such proof unobtainable. In the absence of histological confirmation therefore in patients presenting with a suggestive history, this study would suggest that the most useful investiga- 
